Literature DB >> 23117336

Benign metastasizing leiomyoma of the lung: report of a case.

Akira Mogi1, Junko Hirato, Takayuki Kosaka, Ei Yamaki, Hiroyuki Kuwano.   

Abstract

A 35-year-old female presented with multiple bilateral pulmonary nodules on a chest X-ray during a regular health checkup. Chest computed tomography revealed multiple well-defined nodular shadows in the lung. She had undergone a myomectomy 7 years previously for leiomyoma of the uterus. Thoracoscopic resection of one of the nodules was performed to establish a pathological diagnosis. Pathological findings were consistent with benign metastasizing leiomyoma. Estrogen and progesterone receptors showed strong positives by immunohistostaining of the tumor. The patient is currently receiving outpatient treatment for a benign metastasizing leiomyoma by administration of a GnRH analog drug.

Entities:  

Mesh:

Year:  2012        PMID: 23117336     DOI: 10.1007/s11748-012-0174-4

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  16 in total

1.  Cutaneous leiomyomas lack estrogen and progesterone receptor immunoreactivity.

Authors:  K M McGinley; S Bryant; A A Kattine; J F Fitzgibbon; P B Googe
Journal:  J Cutan Pathol       Date:  1997-04       Impact factor: 1.587

Review 2.  Benign metastasizing leiomyoma. A case report and review of the literature.

Authors:  D J Parenti; T F Morley; J C Giudice
Journal:  Respiration       Date:  1992       Impact factor: 3.580

3.  Metastasizing fibroleiomyoma of the uterus: Report of a case and review of the literature.

Authors:  P E Steiner
Journal:  Am J Pathol       Date:  1939-01       Impact factor: 4.307

Review 4.  Regression of uterine low-grade smooth-muscle tumors metastatic to the lung after oophorectomy.

Authors:  N R Abu-Rustum; J P Curtin; M Burt; W B Jones
Journal:  Obstet Gynecol       Date:  1997-05       Impact factor: 7.661

5.  Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis.

Authors:  Kurt T Patton; Liang Cheng; Veronica Papavero; Matthew G Blum; Anjana V Yeldandi; Brian P Adley; Chunyan Luan; Leslie K Diaz; Pei Hui; Ximing J Yang
Journal:  Mod Pathol       Date:  2006-01       Impact factor: 7.842

Review 6.  Hormonal manipulation of benign metastasizing leiomyomas: report of two cases and review of the literature.

Authors:  J A Rivera; S Christopoulos; D Small; M Trifiro
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

Review 7.  Non-surgical management of leiomyoma: impact on fertility.

Authors:  David L Olive; Steven R Lindheim; Elizabeth A Pritts
Journal:  Curr Opin Obstet Gynecol       Date:  2004-06       Impact factor: 1.927

Review 8.  Pulmonary metastases (with admixed epithelial elements) from smooth muscle neoplasms. Report of nine cases, including three males.

Authors:  M Wolff; F Silva; G Kaye
Journal:  Am J Surg Pathol       Date:  1979-08       Impact factor: 6.394

9.  Pulmonary metastases from benign-appearing smooth muscle tumors of the uterus.

Authors:  D Bachman; M Wolff
Journal:  AJR Am J Roentgenol       Date:  1976-09       Impact factor: 3.959

10.  Benign metastasizing leiomyoma of the lung: PET findings.

Authors:  Valerio di Scioscio; Paola Feraco; Laura Miglio; Francesco Toni; Deborah Malvi; Angela M G Pacilli; Luca Fasano; Mario Fabbri; Maurizio Zompatori
Journal:  J Thorac Imaging       Date:  2009-02       Impact factor: 3.000

View more
  3 in total

1.  Benign metastasizing leiomyoma and 18-FDG-PET/CT: A case report and literature review.

Authors:  Yusuke Sawai; Toshiki Shimizu; Yuta Yamanaka; Maiko Niki; Shosaku Nomura
Journal:  Oncol Lett       Date:  2017-07-19       Impact factor: 2.967

2.  Pulmonary benign metastasizing leiomyoma: a case report and literature review.

Authors:  Shi Chen; Rui-Ming Liu; Tian Li
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

3.  Benign metastasizing leiomyoma of the lung.

Authors:  Eun Young Ki; Seon Jeong Hwang; Keun Ho Lee; Jong Sup Park; Soo Young Hur
Journal:  World J Surg Oncol       Date:  2013-10-17       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.